Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.

ABSTRACT:

Background

World Health Organization expert groups recommended mortality trials of four repurposed antiviral drugs - remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a - in patients hospitalized with coronavirus disease 2019 (Covid-19).

Methods

We randomly assigned inpatients with Covid-19 equally between one of the trial drug regimens that was locally available and open control (up to five options, four active and the local standard of care). The intention-to-treat primary analyses examined in-hospital mortality in the four pairwise comparisons of each trial drug and its control (drug available but patient assigned to the same care without that drug). Rate ratios for death were calculated with stratification according to age and status regarding mechanical ve

SUBMITTER: WHO Solidarity Trial Consortium 

PROVIDER: S-EPMC7727327 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature